Ta
Director, Global Regulatory Affairs, Neuroscience
Takeda Pharmaceutical
Permanent
Massachusetts, Boston
Sales & Marketing
Posted:
June 16, 2026
Location:
Massachusetts, Boston, United States
Job Description
By clicking the Apply button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda's Privacy Notice and Terms of Use . I further attest that all information I submit in my employment application is true to the best of my knowledge.
Job Description
About the role: At Takeda, we are a forward-looking, world-class R&D organization that unlocks innovation and delivers transformative therapies to patients. By focusing R&D efforts on four therapeutic areas and other targeted investments, we push the boundaries of what is possible in order to bring life-changing therapies to patients worldwide.
The Director Global Regulatory Affairs, Neuroscience is responsible for developing innovative global regulatory strategies and providing strategic regulatory guidance for the global development of various products within the Neuroscience Therapeutic A...
Job Description
About the role: At Takeda, we are a forward-looking, world-class R&D organization that unlocks innovation and delivers transformative therapies to patients. By focusing R&D efforts on four therapeutic areas and other targeted investments, we push the boundaries of what is possible in order to bring life-changing therapies to patients worldwide.
The Director Global Regulatory Affairs, Neuroscience is responsible for developing innovative global regulatory strategies and providing strategic regulatory guidance for the global development of various products within the Neuroscience Therapeutic A...
Apply for this Job
Submit your application for the Director, Global Regulatory Affairs, Neuroscience position at Takeda Pharmaceutical.
Apply Now Save for LaterJob Overview
Job Type:
Permanent
Location:
Massachusetts, United States
Posted:
June 16, 2026
Deadline:
July 26, 2026